VRTX
#127
Vertex Pharmaceuticals Incorporated - Common Stock
471.3 2 USD
-0.01%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.05%
Variación mensual
+4.45%
Variación en los últimos 6 meses
+7.01%
Cambio anual
+1.34%
Cierres anteriores
476.3 1
Open
472.2 5
Mínimo
470.7 5
High
475.4 8
Volumen
284
Financials
- Market Capitalization 119.62 B
- Employee 6 400
- Founded 1989
- CEO Reshma Kewalramani
- Website www.vrtx.com
- Headquarter Massachusetts, United States
- FIGI BBG000C1S2X2
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
26.5
Relación precio/flujo de caja
9.42
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 244 |  REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 657.47 USD | +0.21% | -1.44% | +6.72% | +19.53% | 68.93 B USD | ||
| 301 |  ARGX argenx SE - American Depositary Shares | 862.68 USD | +0.38% | -5.88% | -2.17% | +54.51% | 53.39 B USD | ||
| 375 |  RVMD Revolution Medicines, Inc. - Common Stock | 182.68 USD | -1.24% | -5.12% | +15.58% | +229.75% | 38.84 B USD | ||
| 387 |  ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 280.03 USD | -0.44% | -12.26% | -2.81% | -10.03% | 37.39 B USD |